Skip to main content
Demo
Company record · Kortenberg
Belgian companySituation normaleSociété anonyme

BIOPHARM

Enterprise number
0438.547.292
VAT number
BE0438547292
Registered office
Stationstraat 8, 3070 Kortenberg
See the 2 companies at this address
Incorporated on
10 October 1989
Website016622141
Official sources·CBE·NBB: Central Balance Sheet Office·Belgian Official Gazette·Map
Latest financial year
2025
m07-f model
Size
Not published
Workforce not declared
Equity
€5.4M
Financial year 2025
Net result
-€43.5K
Financial year 2025

Profile

Official information from the CBE (FPS Economy).

BIOPHARM is a Belgian company (Société anonyme) whose registered office is established at 3070 Kortenberg. Its main activity falls under “Commerce de détail de produits pharmaceutiques” (NACE 47730).

Legal form
Société anonyme
Legal situation
Situation normale
Date of incorporation
10 October 1989
Main activity (NACE)
47730Commerce de détail de produits pharmaceutiques

An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more

Secondary activities

5 additional NACE codes declared.

Your risk analysis on this company

AML Company ran BIOPHARM through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Establishments

8 active establishment units declared with the CBE.

2
Implantation
Kortenberg

8 establishments · 7 municipalities

Registered office8 establishments
Registered office
Stationstraat 8
3070 Kortenberg
Map
Establishment2045.419.204
Peperstraat 19
3300 Tienen
Map
Establishment 22045.419.303
Stationstraat 8
3070 Kortenberg
Map
Establishment 32226.333.310
Staatsbaan(LUB) 85
3210 Lubbeek
Map
Establishment 42182.947.485
Molenzijde 3
2330 Merksplas
Map
Establishment 52182.947.881
Wolfshaegen 74
3040 Huldenberg
Map

Finances & financial health

Multi-year summary extracted from the annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium).

Financial trend

Equity & result

EquityResult
Key figures by financial year
Financial yearEquityResult
2025€5,369,834-€43,547
2022€5,503,487-€70,526
2021€5,574,013-€74,160
2020––

Financial ratios

Solvency, liquidity and profitability, computed year by year from the filed annual accounts.

Solvency
44,7%
2%
Financial year 2025

Equity / balance sheet total

Liquidity
2,03 x
0,17
Financial year 2025

Current assets / debts due within one year

Net margin
-0,4%
0,5%
Financial year 2025

Result for the year / turnover

Operating margin
1,8%
2,2%
Financial year 2025

Operating result / turnover

Long-term debt
24,9%
0,5%
Financial year 2025

Debts due after one year / balance sheet total

Return on equity
-0,8%
0,5%
Financial year 2025

Result for the year / equity

Over the most recent filed years

Balance sheet structure

SolvencyLong-term debt
Year-on-year comparison
Ratio202520222021Trend
Solvency
44,7%
2%
46,8%
3,4%
50,2%
Liquidity
2,03 x
0,17
1,86 x
0,11
1,97 x
Net margin
-0,4%
0,5%
-0,9%
0,1%
-1%
Operating margin
1,8%
2,2%
-0,3%
0,5%
0,1%
Long-term debt
24,9%
0,5%
25,3%
2,3%
23%
Return on equity
-0,8%
0,5%
-1,3%
flat
-1,3%

Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.

Filing history (6)▾
Financial yearFilingFiling typeModelSource
01/10/2024 → 30/09/202530/04/2026Initialm07-fBNB
01/10/2021 → 30/09/202230/03/2023Initialm07-fBNB
01/10/2020 → 30/09/202113/04/2022Initialm01-fBNB
01/10/2019 → 30/09/202030/04/2021Initialm01-fBNB
01/10/2018 → 30/09/201914/05/2020Initialm01-fBNB
01/10/2017 → 30/09/201829/04/2019Initialm01-fBNB

Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

Frequently asked questions about BIOPHARM

Quick answers on BIOPHARM's identity, contact details and official CBE information.

What is BIOPHARM's enterprise number (CBE)?
BIOPHARM's official enterprise number with the Crossroads Bank for Enterprises (CBE) is 0438547292. This unique number identifies the company with every Belgian administration.
What is BIOPHARM's VAT number?
BIOPHARM's intra-Community VAT number is BE0438547292. It is the CBE number prefixed with “BE” and enables trade within the European Union.
Where is BIOPHARM's registered office?
BIOPHARM's registered office is located at Stationstraat 8, 3070 Kortenberg, Belgium. This address is the official one declared with the CBE.
What is BIOPHARM's legal form?
BIOPHARM is incorporated under the legal form “Société anonyme”. This form determines its legal and tax regime and its publication duties towards the Belgian Official Gazette.
When was BIOPHARM incorporated?
BIOPHARM was entered in the Crossroads Bank for Enterprises on 10 October 1989. This date is the official start of activity declared with the CBE.
Is BIOPHARM still active?
Yes, BIOPHARM is currently listed as an active company with the Crossroads Bank for Enterprises (CBE).
What is BIOPHARM's main activity?
BIOPHARM's declared main activity is: Commerce de détail de produits pharmaceutiques (NACE code 47730). This NACE code officially classifies the company in the European nomenclature of economic activities.
How can BIOPHARM be contacted?
You can contact BIOPHARM by phone on 016622141, through its website https://www.biopharm.be. These details come from the public information declared with the CBE.
How many establishments does BIOPHARM have?
BIOPHARM declares 8 establishment units registered with the CBE, on top of its registered office.
Has BIOPHARM filed its annual accounts?
Yes. BIOPHARM's latest annual accounts were filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) on 30 April 2026, for the financial year ended 30 September 2025. The filings can be consulted publicly with the NBB.
Which official notices concern BIOPHARM?
7 official notices about BIOPHARM are available in the Belgian Official Gazette: incorporation, changes to the articles, appointments, dissolutions. Every one of these acts is listed on this page with a link to the official PDF.
Is BIOPHARM subject to anti-money-laundering obligations in Belgium?
On the face of it, no. BIOPHARM's declared activity is not among the professions expressly covered by the Act of 18 September 2017. This general information is not legal advice.

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
13 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2026
    1. 30 April 2026Annual accounts filed·Financial year ended 30 September 2025 · Model m07-fFiled accounts2026-00103372
  2. 2025
    1. 21 October 2025Appointments · ResignationsView the notice25133445
  3. 2023
    1. 30 March 2023Annual accounts filed·Financial year ended 30 September 2022 · Model m07-fFiled accounts2023-00055240
  4. 2022
    1. 13 April 2022Annual accounts filed·Financial year ended 30 September 2021 · Model m01-fFiled accounts2022-20003843
  5. 2021
    1. 30 April 2021Annual accounts filed·Financial year ended 30 September 2020 · Model m01-fFiled accounts2021-12900165
  6. 2020
    1. 14 May 2020Annual accounts filed·Financial year ended 30 September 2019 · Model m01-fFiled accounts2020-12100594
  7. 2019
    1. 10 December 2019Appointments · ResignationsView the notice19160436
    2. 29 April 2019Annual accounts filed·Financial year ended 30 September 2018 · Model m01-fFiled accounts2019-11700116
    3. 4 February 2019Capital · SharesView the notice19017658
  8. 2014
    1. 27 February 2014Appointments · ResignationsView the notice14052171
  9. 2007
    1. 24 October 2007Capital · Shares · Appointments · Resignations · RestructuringView the notice07155530
    2. 27 August 2007Restructuring · MiscellaneousView the notice07126184

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
Unlock AI insightsSee the plans

Similar companies

Same business sector and geographic area.

APOTHEEK ROOSENS

0461.662.491
3070 Kortenberg

PHARM-OZ

0401.670.169
6060 Charleroi

PHARMACIE SAINTE-MARIE

0401.948.796
1030 Schaerbeek

APOTHEEK KIRSTEN TUYTELEERS

0403.675.792
2620 Hemiksem

Apoteek't Groen Kruis

0403.720.730
2900 Schoten

APOTHEEK DE KEMPEN

0404.149.609
2300 Turnhout

Apotheek van het Museum

0404.812.474
2000 Antwerpen

APOTHEEK DE LAET

0405.063.684
9100 Sint-Niklaas

APOTHEEK CREMERS

0405.238.977
8470 Gistel
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

Create an account

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, anonymised audience-measurement cookies (hosted in the EU) to improve our services. Learn more.